Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease
/in International Publications, Newcastle Disease Virus, Urothelial CarcinomaCurrent status of clinical trials assessing oncolytic virus therapy for urological cancers
/in Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial CarcinomaEmerging role of immunotherapy in urothelial carcinoma-Advanced disease
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial CarcinomaImmunotherapy for the Treatment of Urothelial Carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial CarcinomaRecent advances in immuno-oncology and its application to urological cancers
/in Dendritic Cells, Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial CarcinomaNovel immunotherapeutic approaches to the treatment of urothelial carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial CarcinomaDendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer
/in Dendritic Cells, International Publications, Urothelial CarcinomaThe immunotherapy of prostate and bladder cancer
/in International Publications, Urothelial Carcinoma[Combined radiotherapy and endovascular x-ray therapy for invasive cancer of the urinary bladder]
/in Dendritic Cells, International Publications, Urothelial Carcinoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- The Complexity of Malignant Glioma Treatment
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature